Chemox Pharma offer pharma grade high quality grade (3S)-3-[4-[(5-Bromo-2-chlorophenyl) methyl] phenoxy] tetrahydrofuran (CAS No.: 915095-89-5), that ensures reliable sourcing and transparent communication. Chemox Pharma is an ISO 9001:2015 certified company based in India which supplies Cas No. 915095-89-5 along with full wide range of intermediates.
Chemox Pharma offers affordable pricing, assured quality and access to global regulatory documents that meets your exact specifications. If you are looking for trustable manufacturer of Cas No. 915095-89-5, Chemox Pharma is the ideal choice that can provide high quality sourcing of API and Intermediates.
| . No. | Description | Application |
|---|---|---|
| 1 | Chiral tetrahydrofuran intermediate | API synthesis |
| 2 | Halogenated aromatic ether building block | Medicinal chemistry |
| 3 | Enantiomerically pure heterocyclic intermediate | Pharmaceutical R&D |
| 4 | Bromo-chloro aromatic intermediate | Drug development |
| 5 | Specialty chiral intermediate | Fine chemical synthesis |
This compound is widely used in pharmaceutical research and development as a chiral halogenated aromatic tetrahydrofuran intermediate.
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran should be handled according to standard pharmaceutical intermediate and laboratory chemical safety procedures. Appropriate industrial hygiene and protective measures must be followed during handling and synthesis operations.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of dust and contact with skin or eyes
Handle in controlled, well-ventilated environments
Follow chemical handling and containment protocols
Refer to Safety Data Sheet (SDS) for detailed safety information
This compound is intended strictly for pharmaceutical intermediate and research use.
As a chiral pharmaceutical intermediate, (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran does not exhibit direct pharmacological activity. It functions as an enantiomerically pure tetrahydrofuran-aryl ether building block in multi-step organic synthesis pathways for active pharmaceutical ingredients. The bromine and chlorine substituents enable selective substitution and cross-coupling reactions, while the chiral tetrahydrofuran ring provides stereochemical control in medicinal chemistry and drug development.
Handle in approved chemical or pharmaceutical facilities
Avoid exposure without protective equipment
Prevent dust formation and inhalation
Follow laboratory and industrial safety procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain cool, dry storage conditions
Keep in designated chemical storage areas
Follow standard warehouse practices
It is a chiral aromatic pharmaceutical intermediate used in advanced API synthesis, medicinal chemistry research, and development of specialty drug compounds.
Yes, Chemox Pharma manufactures and supplies (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran (CAS 915095-89-5) with high purity for pharmaceutical synthesis applications.
It is a chiral tetrahydrofuran-aryl ether intermediate containing bromine and chlorine aromatic substituents used as a building block in pharmaceutical synthesis.
No, it is a pharmaceutical intermediate used in API synthesis and does not exhibit direct therapeutic activity.
It should be stored in tightly sealed containers in a cool, dry place protected from moisture and light, following standard chemical storage practices.
Chemox Pharma is a leading and a top Deferoxamine Mesylate manufacturer in India, supplying high-quality pharmaceutical-grade APIs to global markets. Deferoxamine Mesylate
Chemical Name: Benfotiamine (S-benzoylthiamine O-monophosphate) CAS Number: 22457-89-2 Molecular Formula: C₁₉H₂₃N₄O₆PS Molecular Weight: 466.45 g/mol Therapeutic Uses: Diabetic neuropathy, neuroprotection, nerve &
API name/end use: Sartan family Cas number: 124750-51-2 Molecular formula: C33H25BrN4 Molecular Weight: 557.48 Appearance: Solid Powder Storage: Room Temperature (Recommended in